Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
12005
Check minimum number of events None
12005
Extra metadata
HYPOT_THYRO_INCL
No definition available.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
12005
Check minimum number of events None
12005
Extra metadata
List of similar endpoints to Hypotyreosis and Thyroxin purchase for inclusion criteria based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 38626 | 30946 | 7680 |
Unadjusted prevalence (%) | 12.52 | 17.83 | 5.69 |
Mean age at first event (years) | 52.04 | 50.52 | 58.15 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.02 | 1.35 [1.18, 1.55] | 1.9e-5 | 2432 |
15 years | 0.01 | 0.95 [0.84, 1.08] | 4.4e-1 | 1219 |
5 years | 0.00 | 1.71 [1.50, 1.95] | 1.9e-15 | 629 |
1 year | 0.00 | 1.73 [1.39, 2.16] | 8.7e-7 | 117 |
Index endpoint: HYPOT_THYRO_INCL – Hypotyreosis and Thyroxin purchase for inclusion criteria
GWS hits:
before Hypotyreosis and Thyroxin purchase for inclusion criteria
after Hypotyreosis and Thyroxin purchase for inclusion criteria
Loading survival analyses plot
Loading survival analyses table